www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Health

Drugs from overseas to get on fast track

By WANG XIAODONG | China Daily | Updated: 2017-07-14 07:50

Regulators, pharmaceutical companies, researchers will adopt global standards

China will continue to intensify international exchanges and cooperation in drug supervision to promote the domestic application of new medicines developed overseas to meet demand, China's top drug regulator said on Thursday.

The drug authorities will also encourage the domestic pharmaceutical industry to improve its capacity and competitiveness to promote the international visibility of Chinese medical and pharmaceutical products, Wu Zhen, vice-minister of the China Food and Drug Administration, said at the opening ceremony of the BRICS Meeting on Drug Regulatory Collaboration in Zhengzhou, Henan province.

On June 19, the administration announced it joined the International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, which focuses on guidelines for worldwide pharmaceutical development.

"Joining the council means the Chinese drug regulatory authorities, pharmaceutical industry and research and development institutes will gradually adopt internationally accepted standards and guidelines, actively participate in the formulation of international rules and promote quicker domestic application of new drugs developed in other countries," Wu said.

China is the second-largest market for pharmaceutical products in the world. Annual revenues of the pharmaceutical industry in China exceed 2.5 trillion yuan ($368.6 billion), and annual exports of pharmaceutical products exceed 13.5 billion yuan, Wu said.

"China has great pharmaceutical production capacity, so it can provide support to the health of the people in BRICS nations and other countries," he said.

BRICS comprises Brazil, Russia, India, China and South Africa.

The administration has adopted a series of reform measures on the review and approval of new drugs to accelerate approvals and meet the needs of domestic patients in recent years, Wu said.

The authorities will encourage medical institutions to give priority to new drugs that have proved effective and are reasonably priced, and support the inclusion of such new drugs in the list of drugs whose cost can be reimbursed by basic medical insurance programs, according to a draft regulation released by the administration in May.

Certain types of drugs and medical equipment already in use in other countries, such as those for curing rare diseases, can also gain priority approval for sale in the domestic market, the draft said.

As of the end of June, the administration had established routine work relations with drug regulatory authorities in 66 countries, and signed 42 agreements for bilateral cooperation with 28 countries and regions, said Yuan Lin, chief of the administration's international cooperation department.

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美毛片一级的免费的 | 亚洲国产成人久久精品图片 | 波多野结衣在线观看3人 | 亚州男人天堂 | 香港三级日本三级三级人妇 | 亚洲精品一区国产二区 | 最新怡红院全部视频在线 | 一区二区精品视频 | 91视频国产精品 | 69欧美另类xxxxx高清 | 国产成人亚洲综合91精品555 | 欧美怡红院免费的视频 | 亚洲一区欧洲一区 | 美国一级特a黄 | 亚洲在线偷拍自拍 | 日本a级片免费观看 | 91成人爽a毛片一区二区 | 亚洲天堂最新网址 | 国内精品久久久久久野外 | 免费在线看a | 亚洲国产天堂久久综合网站 | 亚洲波多野结衣日韩在线 | 97精品国产91久久久久久久 | 香港一级特黄高清免费 | 日本高清免费视频www | 草草影院ccyy | 午夜亚洲国产成人不卡在线 | 国产视频高清在线 | 国产伦精品一区二区三区网站 | 久久草在线 | 怡红院视频在线 | 日韩欧美一级毛片视频免费 | 久久久久久久综合色一本 | 欧洲亚洲一区 | 国产一区二区三区欧美精品 | 手机在线观看亚洲国产精品 | 亚洲国产专区 | 国产日韩欧美一区二区三区在线 | 六月丁香婷婷天天在线 | 国产中文字幕在线观看 | 国产在线精品一区二区夜色 |